Basic info
Industry
biotechnology research
Sectors
autoimmune diseases
neoantigen
Biotechnology
immunomonitoring
infectious diseases
cytographer
biomarker
oncology
vaccine
Immunoprofiling
immunotherapy
Medical
mass cytometry
CyTOF
Life Science
T cell antigens
Date founded
2016
Funding rounds raised
Total raised
$14M
from 5 investors over 5 rounds
i
immunoSCAPE raised $14M on September 20, 2022
Investors: Anzu Partners and EDBI Pte Ltd
i
immunoSCAPE raised $14M on April 14, 2021
Investors: Anzu Partners and EDBI Pte Ltd
i
immunoSCAPE raised $11M on August 12, 2020
Investors: Anzu Partners